VTVT vTv Therapeutics Inc.
Nasdaq · SEC CIK 1641489 · EDGAR
- Bought, last 12 months
- $0 0 purchases by 0 insiders
- Sold, last 12 months
- $0 0 sales by 0 insiders
- Filings on record
- 50 since 2021-10-21, latest 2026-06-29 16:41
BoughtSold
Most active insiders, 12 months
| Insider | Title | Bought | Sold |
|---|---|---|---|
| No open-market trades in the last year. | |||
Transactions 9
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DI | 2025-09-25 | 2025-09-22 | VTVT | AKKARAJU SRINIVAS | Dir | A - Grant | $15.27 | +106.0K | 106.0K | New | +$1.62M |
| DMI | 2025-09-05 | 2025-09-03 | VTVT | BAKER JULIAN | Dir | A - Grant | — | +51.0K | 12.4K | New | — |
| DI | 2024-12-06 | 2024-03-05 | VTVT | AKKARAJU SRINIVAS | Dir, 10% | D - Sale to Iss | — | -58.8K | 206.8K | -22% | — |
| DI | 2024-12-06 | 2024-03-05 | VTVT | Samsara BioCapital, L.P. | 10% | J - Other | — | -58.8K | 206.8K | -22% | — |
| M | 2024-11-19 | 2024-11-15+ | VTVT | SEKHRI PAUL J | Pres, CEO, Exec COB, Dir | P - Purchase | $16.76 | +5,000 | 1,378 | New | +$83.8K |
| DMI | 2024-03-07 | 2024-03-05 | VTVT | 667, L.P. | Dir | D - Sale to Iss | $0.00 | -57.7K | 89.3K | -39% | $0 |
| DI | 2024-02-29 | 2024-02-27 | VTVT | AKKARAJU SRINIVAS | Dir, 10% | A - Grant | $11.81 | +224.7K | 265.6K | +550% | +$2.65M |
| M | 2022-11-30 | 2022-11-28+ | VTVT | FRY JOHN A | Dir | P - Purchase | $0.83 | +61.0K | 61.0K | New | +$50.6K |
| I | 2021-12-21 | 2021-12-20 | VTVT | PERELMAN RONALD O | 10% | S - Sale | $1.15 | -87.0K | 36.52M | -0.2% | -$100.0K |
Purchase Sale Sale after option exercise All abbreviations